Suppr超能文献

人红细胞钙蛋白酶抑制蛋白的纯化及某些性质

Purification and some properties of human erythrocyte calpastatin.

作者信息

Takano E, Murachi T

出版信息

J Biochem. 1982 Dec;92(6):2021-8. doi: 10.1093/oxfordjournals.jbchem.a134134.

Abstract

Calpastatin, an endogenous inhibitor protein specifically acting on calpain [EC 3.4.22.17; Ca2+-dependent cysteine proteinase], was purified to apparent homogeneity from the cytosol fraction of human erythrocytes. The yield was 0.38 mg from 400 ml of blood. The purification procedures included DEAE-cellulose and Ultrogel AcA34 gel chromatographies followed by heat treatment and a final gel chromatography on Sephacryl S-200, from which calpastatin was eluted at a position corresponding to a 280,000-dalton molecular mass. The heat treatment at 100 C for 15 min at pH 7.5 very effectively removed contaminant proteins. The homogeneity of the final product was demonstrated on polyacrylamide gel electrophoresis in the presence of sodium dodecylsulfate, giving a single protein band with a calculated molecular weight of 70,000. After re-extraction from the gel, the 70,000-dalton protein readily reassociated to give a 280,000-dalton peak upon Sephacryl S-200 chromatography with a recovery of total inhibitory activity of 42%. Purified calpastatin had an isoelectric point at pH 4.55. It had glutamine as the amino-terminal residue. Amino acid analyses revealed that it contained relatively large amounts of proline, glutamic acid, and lysine, smaller amounts of aromatic amino acids, notably no tryptophan, and no amino sugars. The content of half-cystine was less than one per 643 amino acid residues. These features are in general agreement with those of the reported amino acid composition of Ca2+-protease inhibitor from chicken skeletal muscle [Ishiura et al. (1982) Biochim. Biophys. Acta 701, 216-223], although these inhibitors were found to be definitely different in several other respects. Human erythrocyte calpastatin could inhibit not only calpain of the same origin but also calpains having low and high Ca2+-sensitivity from rat liver.

摘要

钙蛋白酶抑制蛋白是一种特异性作用于钙蛋白酶[EC 3.4.22.17;钙依赖性半胱氨酸蛋白酶]的内源性抑制蛋白,从人红细胞的胞质溶胶部分纯化至表观均一。从400毫升血液中获得的产量为0.38毫克。纯化步骤包括DEAE-纤维素和Ultrogel AcA34凝胶色谱,随后进行热处理,最后在Sephacryl S-200上进行凝胶色谱,钙蛋白酶抑制蛋白在对应于280,000道尔顿分子量的位置洗脱。在pH 7.5下于100℃热处理15分钟非常有效地去除了污染蛋白。在十二烷基硫酸钠存在下的聚丙烯酰胺凝胶电泳证明了最终产物的均一性,得到一条计算分子量为70,000的单一蛋白带。从凝胶中重新提取后,70,000道尔顿的蛋白很容易重新缔合,在Sephacryl S-200色谱上产生一个280,000道尔顿的峰,总抑制活性回收率为42%。纯化的钙蛋白酶抑制蛋白的等电点为pH 4.55。其氨基末端残基为谷氨酰胺。氨基酸分析表明,它含有相对大量的脯氨酸、谷氨酸和赖氨酸,少量的芳香族氨基酸,尤其是不含色氨酸,也不含氨基糖。每643个氨基酸残基中半胱氨酸的含量少于一个。这些特征与报道的鸡骨骼肌钙蛋白酶抑制剂的氨基酸组成总体一致[石浦等人(1982年)《生物化学与生物物理学报》701,216 - 223],尽管发现这些抑制剂在其他几个方面肯定不同。人红细胞钙蛋白酶抑制蛋白不仅可以抑制同源的钙蛋白酶,还可以抑制来自大鼠肝脏的具有低和高钙敏感性的钙蛋白酶。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验